Xeris Pharmaceuticals (2B30) Revenue

0 Followers

Xeris Pharmaceuticals Revenue

Xeris Pharmaceuticals had a revenue of 92.10M in the quarter ending Jun 30, 2026, with 10.79%. This bring the company's revenue in the last twelve months to 335.41M, Decreased 6.53%. In the fiscal year ending Dec 31, 2025, Xeris Pharmaceuticals had annual revenue of 291.85M with 43.72% growth.

Revenue (ttm)

335.41M

Revenue Growth

27.28%

P/S Ratio

4.58

Revenue/Employee

€670,908

Employees

435

Market Cap

€1.34B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	291.85M	88.78M	+43.72%
Dec 31, 2024	203.07M	39.16M	+23.89%
Dec 31, 2023	163.91M	53.67M	+48.68%
Dec 31, 2022	110.25M	60.66M	+122.32%
Dec 31, 2021	49.59M	29.16M	+142.67%
Dec 31, 2020	20.43M	17.71M	+650.73%
Dec 31, 2019	2.72M	257.00K	+10.43%
Dec 31, 2018	2.46M	909.00K	+58.42%
Dec 31, 2017	1.56M	―	―